Whalesbook
### Solar Sector Faces U.S. Tariff Headwinds
The imposition of preliminary U.S. countervailing duties, set at a substantial 126% on solar imports from India, sent shockwaves through the domestic solar manufacturing industry. This development, stemming from allegations of unfair subsidization, led to immediate and sharp declines in exporter-heavy stocks. Waaree Energies, with a significant export revenue stream, saw its shares plummet by as much as 14.2% [cite: Source A]. Premier Energies and Vikram Solar also experienced considerable drops of over 10% and 7.5% respectively [cite: Source A]. While Premier Energies has negligible export exposure, its stock movement indicated sentiment spillover. Vikram Solar, which has approximately 16% export exposure, and Waaree Energies with around 29% exposure, bore the direct brunt of the news [cite: Source A]. The impact was not uniform across the sector; Borosil Renewables experienced a more modest decline, and companies like Servotech Renewable Power System traded marginally higher, suggesting selective market reactions. India is projected to become the world's second-largest solar market in 2026, but such trade actions pose a significant threat to its export-driven growth ambitions. Global solar installations are expected to contract in 2026, further complicating the outlook for Indian manufacturers reliant on international markets.
### IT Index Recovers Amidst Broader Market Strength
The Nifty IT index demonstrated resilience, rebounding by 3.14% following a challenging month marked by significant investor concerns over artificial intelligence's disruptive potential. HCL Technologies and Infosys led the recovery, with share prices rising over 3% and nearly 3% respectively, accompanied by similar gains in TCS and Wipro [cite: Source A]. This uptick suggests a temporary abatement of fears surrounding AI-driven automation impacting service models and pricing power. However, the underlying concerns persist, with the Nifty IT index having shed approximately $68.6 billion in market capitalization in February alone. Valuations for Indian IT majors like TCS (P/E ~19.56-23.96) and Infosys (P/E ~18.4-19.24) remain elevated compared to global peers such as Accenture (P/E ~17.6-17.8). The sector has historically seen sharp sell-offs during technological shifts, and while current AI fears might be exaggerated for some, the long-term implications for service delivery and client spending remain a critical watchpoint.
### Pharma and Infrastructure Catalysts Drive Gains
Natco Pharma's stock extended its upward trajectory, surging by 4.78% after earlier gains, propelled by the Central Drugs Standard Control Organisation's (CDSCO) approval for Semaglutide in India [cite: Source A]. The company plans to launch the generic drug in March 2026, capitalizing on the approaching patent expiry of Novo Nordisk's blockbuster drug. This approval places Natco Pharma among several key players, including Eris Lifesciences (which has partnered with Natco), Sun Pharma, and Dr. Reddy's, vying for a share of the rapidly growing diabetes and weight-loss therapy market. Meanwhile, Larsen & Toubro (L&T) witnessed a modest rise in its stock price following significant order wins for its Power Transmission & Distribution vertical, valued between Rs 5,000 crore and Rs 10,000 crore [cite: Source A]. Additional orders for the LIGO India Observatory project further bolstered sentiment around L&T's robust project execution capabilities.
### Government Stake Sale and Block Deals Pressure Stocks
Indian Railway Finance Corporation (IRFC) shares faced downward pressure, declining by 3.9% to a 25-month low, as the government initiated an Offer for Sale (OFS) to divest up to a 4% stake [cite: Source A, 2, 15]. The floor price for the OFS was set at Rs 104 per share, a discount to the previous day's closing price, signaling potential near-term supply overhang. The government aims to raise approximately Rs 5,430 crore through this divestment, which is part of its broader strategy to meet SEBI's minimum public shareholding norms and disinvestment targets. Despite reporting its highest-ever quarterly profit in December 2025, the stock's sentiment was overshadowed by the OFS. Separately, SpiceJet's stock hit its 10% lower circuit amid substantial block deals on the BSE, with approximately 8.4% of its equity changing hands, indicating significant institutional activity [cite: Source A].
### The Valuation Gap and Sectoral Divergence
The market's current trajectory highlights a distinct divergence across sectors. While the U.S. tariffs cast a long shadow over the export-oriented solar manufacturers, creating a potential valuation gap based on future export viability, the IT sector navigates a complex narrative of rebound versus persistent AI-driven disruption risks. Companies heavily reliant on traditional outsourcing models may face margin compression if AI efficiencies lead to reduced billable hours. Conversely, sectors benefiting from specific regulatory approvals and robust order books, such as pharmaceuticals and infrastructure, appear more insulated. The government's continued divestment plans, as seen with IRFC, also introduce a recurring supply factor that can influence short-term stock performance, irrespective of underlying business fundamentals.
### Risk Factors and The Bear Case
For the solar sector, the primary risk remains the long-term impact of increasingly protectionist trade policies from key export markets like the United States. This could necessitate a strategic pivot towards domestic sales, which may not fully compensate for lost export revenues, potentially leading to overcapacity issues given India's expanding manufacturing base. In the IT sector, the existential threat posed by advanced AI tools automating core services cannot be dismissed. Companies with high P/E multiples and significant exposure to routine tasks face greater scrutiny, as AI-driven efficiencies could erode pricing power and revenue growth. Natco Pharma faces competition in the Semaglutide market, and reliance on regulatory approvals for future growth presents inherent risks. L&T, while strong, is exposed to the cyclical nature of infrastructure spending and execution risks. IRFC faces continuous pressure from ongoing government stake sales and a low interest coverage ratio. SpiceJet's operational viability remains under scrutiny due to its precarious financial position and intense competition within the Indian aviation industry.
### The Future Outlook
As India solidifies its position as the world's second-largest solar market, the sector's growth will increasingly depend on domestic demand and policy support, alongside efforts to diversify export markets. The IT sector's ability to integrate AI into its service offerings and demonstrate adaptability will be key to sustaining its valuations. Positive developments in pharmaceuticals and infrastructure are likely to continue, contingent on regulatory pipelines and government spending. The government's disinvestment agenda suggests that supply overhangs, particularly in public sector undertakings like IRFC, will remain a recurring theme. Analyst sentiment towards the IT sector remains cautious, with a watchful eye on AI's long-term disruption potential, while solar exporters navigate a more immediate and tangible trade policy challenge.